Individual statins differ in immunomodulatory potential and capability to treat Th1-mediated CNS autoimmune disease. 5th Annual Meeting of the Federation-of-Clinical-Immunology-Societies Goldstein, M. J., Weber, M. S., Dunn, S. E., Prod'homme, T., Steinman, L., Zamvil, S. S., Youssef, S. ACADEMIC PRESS INC ELSEVIER SCIENCE. 2005: S94–S95

View details for Web of Science ID 000229104400263